Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; 20220101, Issue: Preprints
- Subject
- Language
- ISSN
- 22132600; 22132619